Bringspring Science and Technology Valuation
Is 300290 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 300290 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 300290's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 300290's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 300290?
Other financial metrics that can be useful for relative valuation.
What is 300290's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CN¥8.60b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 10.8x |
Enterprise Value/EBITDA | 208.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 300290's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 6.8x | ||
300075 Beijing eGOVA Co | 11.7x | 25.3% | CN¥9.9b |
300170 HAND Enterprise Solutions | 3.3x | n/a | CN¥8.7b |
301316 Hydsoft TechnologyLtd | 6.1x | n/a | CN¥7.8b |
300348 Shenzhen Sunline Tech | 6x | 16.6% | CN¥9.3b |
300290 Bringspring Science and Technology | 13.1x | n/a | CN¥8.6b |
Price-To-Sales vs Peers: 300290 is expensive based on its Price-To-Sales Ratio (13.1x) compared to the peer average (6.8x).
Price to Earnings Ratio vs Industry
How does 300290's PE Ratio compare vs other companies in the CN IT Industry?
Price-To-Sales vs Industry: 300290 is expensive based on its Price-To-Sales Ratio (13.1x) compared to the CN IT industry average (4.3x).
Price to Sales Ratio vs Fair Ratio
What is 300290's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 13.1x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 300290's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.